hgt-logo
CIRS
language
中文
Log in
Home/News/Details

Upcoming Approval for REACH Registration Testing Proposals for 12 Substances

Jun 13, 2024
EU
REACH
Registration
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

In accordance with REACH regulations, before conducting tests under Annex IX and X (for registration volumes of 100-1000 tons per year and over 1000 tons per year), registrants must submit a testing proposal (TP). After a consultation period, ECHA will finalize the testing requirements based on feedback and the characteristics of the substance.

On May 14, 2024, the European Chemicals Agency (ECHA) announced 12 new substance testing proposals and invited the public to submit their comments by following dates.

ECHA’s public consultation on substance testing proposals is a transparent process to determine if additional testing is needed for chemical registration dossiers to ensure safety. This process gathers input from various stakeholders to improve chemical safety assessments. After the consultation period, ECHA will adjust the testing requirements based on the feedback. Registrants must then conduct the specified tests, submit the results, and update their safety documentation to ensure safe use and promote industry sustainability.

Name EC Num./ CAS Num. Hazard endpoint for which vertebrate testing was proposed Deadline for submitting information
4,4'-methylenebis[N,N-bis(2,3-epoxypropyl)aniline]

249-204-3

28768-32-3

6.1.2 Long-term toxicity to fish 27/05/2024
Dibromomethane

200-824-2

74-95-3

7.6.2 Genetic toxicity in vivo 27/05/2024
Diethyl succinate

204-612-0

123-25-1

7.5.1 Repeated dose toxicity: oral

7.8.2 Developmental toxicity / teratogenicity

27/05/2024
Manganate(1-), glycinato-N,O)[sulfato(2-)-O]-, hydrogen

838-538-0

52139-31-8

7.6.2 Genetic toxicity in vivo 27/05/2024
Menthol

201-939-0

89-78-1

6.1.2 Long-term toxicity to fish 28/06/2024
N,N-dimethylacrylamide

220-237-5 

2680-03-7

7.8.2 Developmental toxicity / teratogenicity 28/06/2024
N-(2-(dimethylamino)ethoxy)ethyl)-N-methyl-1,3-propanediamine

470-720-1

189253-72-3

7.5.1 Repeated dose toxicity: oral

7.8.2 Developmental toxicity / teratogenicity

27/05/2024
N-[3-(dimethylamino)propyl] C6-9 alkyl amides

948-134-7

-

6.1.2 Long-term toxicity to fish 28/06/2024
Polyhydroxy-N,N-polyalkylbenzene-polycarboxamide

-

-

7.5.1 Repeated dose toxicity: oral

7.8.2 Developmental toxicity / teratogenicity

27/05/2024
Sodium chlorite

231-836-6

7758-19-2

6.1.2 Long-term toxicity to fish

7.6.2 Genetic toxicity in vivo

28/06/2024
Tetramethylammonium hydroxide

200-882-9

75-59-2

7.8.2 Developmental toxicity / teratogenicity||Note: testing proposed with Tetramethyl ammonium chloride (EC no. 200-880-8) 28/06/2024
Triisobutyl phosphate

204-798-3

126-71-6

6.1.2 Long-term toxicity to fish 27/05/2024

 

Further Information 

ECHA 1
ECHA 2

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline